 Neoplasm Recurrence, Local
"Neoplasm Recurrence, Local" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
| Descriptor ID |
D009364
|
| MeSH Number(s) |
C04.697.655 C23.550.727.655
|
| Concept/Terms |
Neoplasm Recurrence, Local- Neoplasm Recurrence, Local
- Local Neoplasm Recurrences
- Locoregional Neoplasm Recurrence
- Recurrences, Local Neoplasm
- Neoplasm Recurrences, Local
- Recurrence, Local Neoplasm
- Recurrence, Locoregional Neoplasm
- Local Neoplasm Recurrence
- Neoplasm Recurrence, Locoregional
- Locoregional Neoplasm Recurrences
- Neoplasm Recurrences, Locoregional
- Recurrences, Locoregional Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Recurrence, Local".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Recurrence, Local".
This graph shows the total number of publications written about "Neoplasm Recurrence, Local" by people in this website by year, and whether "Neoplasm Recurrence, Local" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 3 | 4 | | 1997 | 2 | 7 | 9 | | 1998 | 0 | 4 | 4 | | 1999 | 4 | 5 | 9 | | 2000 | 3 | 7 | 10 | | 2001 | 1 | 5 | 6 | | 2002 | 3 | 5 | 8 | | 2003 | 3 | 1 | 4 | | 2004 | 1 | 5 | 6 | | 2005 | 3 | 8 | 11 | | 2006 | 4 | 11 | 15 | | 2007 | 7 | 5 | 12 | | 2008 | 11 | 5 | 16 | | 2009 | 10 | 12 | 22 | | 2010 | 13 | 12 | 25 | | 2011 | 9 | 11 | 20 | | 2012 | 16 | 5 | 21 | | 2013 | 17 | 13 | 30 | | 2014 | 34 | 5 | 39 | | 2015 | 13 | 14 | 27 | | 2016 | 17 | 11 | 28 | | 2017 | 27 | 14 | 41 | | 2018 | 25 | 13 | 38 | | 2019 | 32 | 17 | 49 | | 2020 | 24 | 33 | 57 | | 2021 | 20 | 42 | 62 | | 2022 | 6 | 48 | 54 | | 2023 | 0 | 58 | 58 | | 2024 | 24 | 23 | 47 | | 2025 | 51 | 14 | 65 | | 2026 | 14 | 6 | 20 |
To return to the timeline, click here.
Below are the most recent publications written about "Neoplasm Recurrence, Local" by people in Profiles.
-
Yuza K, Chatzipanagiotou OP, Hobeika C, Aucejo F, Marques HP, Hugh T, Shen F, Maithel SK, Groot Koerkamp B, Popescu I, Weiss MJ, Martel G, Pulitano C, Poultsides G, Ruzzenente A, Bauer TW, Gleisner A, Endo I, Pawlik TM. Metastatic lymph node burden and invasive tumour features inform first recurrence patterns after curative-intent resection for intrahepatic cholangiocarcinoma. Br J Surg. 2026 Jul 02; 113(7).
-
Griesinger AM, Widener M, Donson AM, Mettetal A, Hankinson TC, Handler M, Mulcahy Levy JM, Lindsay HB, Macy ME, Foreman NK, Dorris K. Molecular biology and phase 1 study of GM-CSF and intrathecal trastuzumab in children with recurrent -posterior fossa ependymoma. Neuro Oncol. 2026 Jul 01; 28(7):1783-1793.
-
Yefet LS, Landry AP, Rogers CL, Wang JZ, Liu J, Patil V, Gui C, Ajisebutu A, Ellenbogen Y, Wei Q, Singh O, Mansouri S, Szot C, Jordan RC, Barani IJ, Straza MW, Shu HG, Pointer KB, Hunter G, Panet-Raymond V, Shi W, Perlow HK, Kavanagh BD, Gunter T, Robinson C, Pugh SL, Dicker AP, Mehta MP, Chakravarti A, Nassiri F, Aldape K, Zadeh G. Modern molecular profiling recontextualizes the NRG/RTOG 0539 trial and reveals hidden high-risk and radiotherapy-resistant meningiomas. Neuro Oncol. 2026 Jul 01; 28(7):1727-1740.
-
Cortina CS, Brazauskas R, Flanagan MR, Dill ED, Joseph KP, Trifonov A, Mukhtar RA, Kim EA, Kantor O, Barmettler G, Rezak KM, Rosenberger LH, Jordan SW, Perez MM, Jimenez RB, Smart AC, Kopkash KA, Hughes TM, Walker JC, Lautner MA, Siegel EL, Brabender DE, Al-Hilli Z, Cassidy MR, Weiss A, McCaffrey RL, Lee MC, Kaoutzanis C, Nguyen KN, Son JD, Williams AD, Madrigrano A, McLaughlin SA, Petroll AE, Stolley M. Characteristics of Gender-Diverse Patients With Breast Cancer. JAMA Netw Open. 2026 Jul 01; 9(7):e2624824.
-
Kakos CD, Ziogas IA, Kokkinakis S, Khomiak A, Moris D, Marantos A, Dionysis TT, Schulick RD, Del Chiaro M, Roach JP. Systematic Review and Pooled Analysis of 1,021 Children With Pancreatic Tumors. J Surg Res. 2026 Sep; 325:363-374.
-
Kamdar M, Bartlett NL. From breakthroughs to blueprints: evolving evidence and future directions in relapsed and refractory large B-cell lymphoma. Blood. 2026 Jun 11; 147(24):2879-2894.
-
Hanna GJ, Zandberg DP, Wong DJ, Sherman E, Sacco AG, Yilmaz E, Hernando-Calvo A, Reiners RD, Bohr D, Salazar RL, O'Connell BC, Raben D, Schulten J, Chung CH, Kaczmar J. Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trial. J Clin Oncol. 2026 06 20; 44(18):1697-1708.
-
Alderuccio JP, Baggio D, Han S, Ghione P, Nizamuddin I, Khwaja J, Saha A, Dong N, Wang Y, Cherng HJ, Tolu S, Wagner-Johnston N, Ollila TA, Grover N, Koff JL, Desai A, Ramakrishnan Geethakumari P, Moyo TK, Sandoval-Sus J, Epperla N, Wallace DS, Kamdar M, Tavarozzi R, Danilov A, Tun H, Munoz J, Narkhede M, Rhodes JM, Prica A, Kuhnl A, Maraj A, Okosun J, Smith J, Osborne W, Calvert V, El-Sharkawi D, Hilali A, Collins GP, Linton K, Elmusharaf N, Santarsieri A, Karim F, Baidoun F, Monick SE, Trutzer IM, Can J, Ayers A, Calabrese De Feo J, Sharp J, Ghosh N, Treitman R, Kallam A, Okcu I, Abeyakoon C, Hann W, Barrett A, Deshani V, Kahl BS, Chavez JC, Olszewski AJ, Cwynarski K. Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma. Blood. 2026 Apr 16; 147(16):1814-1827.
-
Wen PY, Berry DA, Buxton MB, Colman H, de Groot J, Lim M, Mellinghoff I, Perry JR, Weller M, Blondin NA, Butt OH, Damek DM, de la Fuente MI, Drappatz J, Dunbar E, Giglio P, Hyddmark EV, Iwamoto F, Jaeckle KA, Kim L, Kling HM, Lee EQ, Mantica M, Mikkelsen T, Nabors B, Newton HB, Olson JJ, Schiff D, Walbert T, Weathers SP, Cloughesy T, Lassman AB. Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial. J Clin Oncol. 2026 06 20; 44(18):1676-1686.
-
Endo Y, Kawashima J, Chatzipanagiotou O, Woldesenbet S, Aucejo F, Marques HP, Lam V, Lesurtel M, Popescu I, Weiss M, Martel G, Poultsides GA, Ruzzenente A, Endo I, Gleisner A, Shen F, Pawlik TM. Machine learning-based clustering differentiates bilateral hepatocellular carcinoma characteristics and prognosis. Surgery. 2026 Jun; 194:110186.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|